Micron Biomedical

News & Press Releases

In The News

Labiotech Spotlights Micron Biomedical as a Leader in Needle-Free Vaccines

February 5, 2025

Endpoints News: “Micron Biomedical has started 2025 on a positive note”

January 16, 2025

Micron Biomedical Recognized as a Breakthrough Scientific Innovation in the Prix Galien Start-Up Category

November 7, 2024

Micron Biomedical Wins the “Biotech Medical Innovation” Award at Boston Biotech Week

October 17, 2024

BBC Spotlights “Extremely Promising” Micron Biomedical Data Publication in The Lancet

May 1, 2024

The Telegraph Spotlights Micron Biomedical Data Publication in The Lancent

May 1, 2024

Press Releases

Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines

January 16, 2025

Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles

January 14, 2025

CEPI and Micron Biomedical Accelerate Needle-Free Vaccines against Disease X with $3.7 Million Grant to Advance Learnings from COVID-19

January 8, 2025

Micron Biomedical Secures $43 Million in Total Grant Support to Improve Coverage of Measles and Rubella Vaccine and Accelerate World’s First Phase 2 Trial of Needle-Free Drug and Vaccine Technology in Infants

January 7, 2025

Micron Biomedical Recognized as a Breakthrough Scientific Innovation in the Prix Galien Start-Up Category

November 7, 2024

Micron Biomedical Wins the “Biotech Medical Innovation” Award at Boston Biotech Week

October 17, 2024